Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Clin Virol. 2017 Oct 24;97:22–25. doi: 10.1016/j.jcv.2017.10.013

Table 3.

Testing HIV-1/HIV-2 dually-seropositive samples

Dual HIV-1/HIV-2
Seropositive Samples
(collection date)		 HIV-1 Alere
Detect
Qualitative
Result* 		HIV-2 Alere
Detect
Qualitative
Result		 HIV-1 Abbott
Results
RNA
copies/mL^ 		HIV-2 UW-
Abbott Results
RNA
copies/mL^
HD01 (07.14.10) Undetected Undetected Undetected Undetected
HD02 (05.04.09) HIV-1 M/N detected Detected 85,120 2,592
HD06 (09.29.09) HIV-1 M/N detected Detected 510,596 311
HD09 (01.06.11) Undetected Undetected Undetected Undetected
HD10 (01.06.11) HIV-1 M/N detected Undetected 13,730 Undetected
HD12 (08.11.11) Undetected Undetected Undetected Undetected
HD13 (09.08.11) Undetected Detected Detected, <40 28,726
HD14 (04.28.11) Undetected Undetected Undetected Undetected
*

All samples were not detected for HIV-1 Group O.

^

Some results listed below were previously published (31).